Reimbursement of research and development expenses by collaborators
Regeneron Pharmaceuticals·Business Segments·1 segment
Breakdown
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Business Segments | -$37.30M | -$42.30M | -$32.80M | -$36.10M | -$33.60M |
| Total | -$37.30M | -$42.30M | -$32.80M | -$36.10M | -$33.60M |
Segments
Business SegmentsView metric